These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21855366)

  • 1. Lipocalin 2 regulation and its complex role in inflammation and cancer.
    Li C; Chan YR
    Cytokine; 2011 Nov; 56(2):435-41. PubMed ID: 21855366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of neutrophil gelatinase-associated lipocalin (NGAL) in the glycolipid metabolism and inflammation].
    Zhu RT; Gong JP
    Sheng Li Ke Xue Jin Zhan; 2012 Jun; 43(3):198-201. PubMed ID: 23019923
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer.
    Kubben FJ; Sier CF; Hawinkels LJ; Tschesche H; van Duijn W; Zuidwijk K; van der Reijden JJ; Hanemaaijer R; Griffioen G; Lamers CB; Verspaget HW
    Eur J Cancer; 2007 Aug; 43(12):1869-76. PubMed ID: 17604154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin-2: pro- or anti-apoptotic?
    Kehrer JP
    Cell Biol Toxicol; 2010 Apr; 26(2):83-9. PubMed ID: 19160065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophil gelatinase-associated lipocalin in gastric carcinoma cells and its induction by TPA are controlled by C/EBPβ.
    Du ZP; Yuan HM; Wu BL; Chang JX; Lv Z; Shen J; Wu JY; Chen HB; Li EM; Xu LY
    Biochem Cell Biol; 2011 Jun; 89(3):314-24. PubMed ID: 21612443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute kidney injury in critically ill infants: the role of urine Neutrophil Gelatinase-Associated Lipocalin (NGAL).
    Mussap M; Degrandi R; Fravega M; Fanos V
    J Matern Fetal Neonatal Med; 2010 Oct; 23 Suppl 3():70-2. PubMed ID: 20807163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In search of early events in the development of chronic kidney disease: the emerging role for lipocalin-2/NGAL.
    Rauen T; Weiskirchen R; Floege J
    Nephrol Dial Transplant; 2011 Feb; 26(2):445-7. PubMed ID: 21273240
    [No Abstract]   [Full Text] [Related]  

  • 8. NGAL controls the metastatic potential of anaplastic thyroid carcinoma cells.
    Volpe V; Raia Z; Sanguigno L; Somma D; Mastrovito P; Moscato F; Mellone S; Leonardi A; Pacifico F
    J Clin Endocrinol Metab; 2013 Jan; 98(1):228-35. PubMed ID: 23150684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury.
    Devarajan P
    Nephrol Dial Transplant; 2008 Dec; 23(12):3737-43. PubMed ID: 18809975
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron metabolism at the host pathogen interface: lipocalin 2 and the pathogen-associated iroA gene cluster.
    Smith KD
    Int J Biochem Cell Biol; 2007; 39(10):1776-80. PubMed ID: 17714976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased NGAL (Lnc2) expression after chemotherapeutic drug treatment.
    Chappell WH; Abrams SL; Stadelman KM; LaHair MM; Franklin RA; Cocco L; Evangelisti C; Chiarini F; Martelli AM; Steelman LS; McCubrey JA
    Adv Biol Regul; 2013 Jan; 53(1):146-55. PubMed ID: 23073564
    [No Abstract]   [Full Text] [Related]  

  • 12. Up-regulated lipocalin-2 in pulmonary hypertension involving in pulmonary artery SMC resistance to apoptosis.
    Wang G; Liu X; Meng L; Liu S; Wang L; Li J; Cui C; Meng J; Hu S; Wei Y
    Int J Biol Sci; 2014; 10(7):798-806. PubMed ID: 25076856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammation-lipocalin 2 axis may contribute to the development of chronic kidney disease.
    Hashikata A; Yamashita A; Suzuki S; Nagayasu S; Shinjo T; Taniguchi A; Fukushima M; Nakai Y; Nin K; Watanabe N; Asano T; Abiko Y; Kushiyama A; Nagasaka S; Nishimura F
    Nephrol Dial Transplant; 2014 Mar; 29(3):611-8. PubMed ID: 24235082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL): a new piece of the anemia puzzle?
    Bolignano D; Coppolino G; Donato V; Lacquaniti A; Bono C; Buemi M
    Med Sci Monit; 2010 Jun; 16(6):RA131-5. PubMed ID: 20512104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome.
    Jang Y; Lee JH; Wang Y; Sweeney G
    Clin Exp Pharmacol Physiol; 2012 Feb; 39(2):194-9. PubMed ID: 21689137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Novel biological involvements of siderophore-binding proteins in hematopoiesis, cell differentiation, tissue injury, carcinogenesis and infections].
    Mori K; Mukoyama M; Nakao K
    Rinsho Ketsueki; 2009 Jul; 50(7):519-26. PubMed ID: 19638718
    [No Abstract]   [Full Text] [Related]  

  • 18. Adipocytokines and insulin resistance: the possible role of lipocalin-2, retinol binding protein-4, and adiponectin.
    Esteve E; Ricart W; Fernández-Real JM
    Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S362-7. PubMed ID: 19875582
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settings.
    Virzì GM; Clementi A; de Cal M; Cruz DN; Ronco C
    Blood Purif; 2013; 35(1-3):139-43. PubMed ID: 23343559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte/macrophage lineage cells.
    Miharada K; Hiroyama T; Sudo K; Danjo I; Nagasawa T; Nakamura Y
    J Cell Physiol; 2008 May; 215(2):526-37. PubMed ID: 18064607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.